Astral Systems
Develops multi-state fusion technology for medical radioisotopes and commercial applications
£23MSeries A
Role not disclosedD
Daphni
Activity from announced rounds
Activity in this selectionJun 30, 2026 · Jun 1, 2026
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $48.4M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionGraph Therapeutics
Develops precision medicines for inflammatory and immune-mediated diseases using AI-powered patient cell analysis
$5MSeries A
Role not disclosedRocapine
Builds wellness apps for women's health, habit-building, and breaking compulsive behaviors
$13MSeries A
Role not disclosed